Christophe Soulier
Director of Finance/CFO at Janssen Pharmaceuticals, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elena Fernandez Kleinlein | F | - |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | 11 years |
| William Hait | M | 74 | 17 years | |
| Steven Hyman | M | 71 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | - |
| Nerida Scott | M | 55 |
Johnson & Johnson Innovation Ltd.
Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | 8 years |
| Elinor Riggs | M | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | - |
| Paul Burton | M | 55 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | - |
| Jennifer Taubert | F | 60 | 19 years | |
| Mats Olsson | M | 71 |
Johnson & Johnson Innovation Ltd.
Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | 21 years |
| Elizabeth Forminard | F | 53 | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James T. Lenehan | M | 75 | 28 years | |
| John Johnson | M | 66 | 19 years | |
| Susan L. Lindquist | M | 74 | - | |
| Stephanie Cuttler Aument | F | - |
University of Michigan
| 2 years |
| Atiba T. Edwards | M | - |
University of Michigan
| 6 years |
| Jeneanne Hanley | F | 51 |
University of Michigan
| 10 years |
| Ajit Shetty | M | 77 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 36 years |
| Jeremy Schneider | M | - |
University of Michigan
| 4 years |
| Evan Norton | M | 49 | 3 years | |
| Michael W. Vostrizansky | M | - |
University of Michigan
| 5 years |
| Becky A. Navin | F | - |
University of Michigan
| 3 years |
| David M. Flannery | M | - |
University of Michigan
| 5 years |
| Vanessa Broadhurst | F | 55 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 16 years |
| Chetan Jain | M | - |
University of Michigan
| 3 years |
| Lisa Romanko | F | - | 19 years | |
| Carla Sivak | F | - | 4 years | |
| Oliver Yucheng Chen | M | 45 |
University of Michigan
| - |
| Christopher DelOrefice | M | 52 | 8 years | |
| Walter Joseph Liu | M | 45 |
University of Michigan
| 5 years |
| Valerie Chase | F | 41 |
University of Michigan
| 5 years |
| Martin Valdes | M | - |
University of Michigan
| 2 years |
| Keenan Kwok | M | - |
University of Michigan
| 5 years |
| Todd Halonen | M | - |
University of Michigan
| 9 years |
| Nathan Pacer | M | - |
University of Michigan
| 4 years |
| Daniel Quigley | M | - |
University of Michigan
| 7 years |
| Denice Torres | F | 64 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 12 years |
| Marc Weiser | M | - |
University of Michigan
| 9 years |
| Joseph Truitt | M | 59 | 4 years | |
| Hemanshu Shah | M | 63 | 1 years | |
| Curtis Selquist | M | 79 | 36 years | |
| Sanjaya Singh | M | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 5 years |
| Charles O. Prince | M | 74 | 17 years | |
| Robert J. Darretta | M | 78 | 39 years | |
| Dave J. Hiemstra | M | - |
University of Michigan
| 2 years |
| Mark LaRosa | M | - |
University of Michigan
| 6 years |
| William Perez | M | 76 | 13 years | |
| Michael Johns | M | 82 | 9 years | |
| Annie Maxwell | F | - |
University of Michigan
| 5 years |
| Jeffrey Thomas Prince | M | - |
University of Michigan
| 15 years |
| Mary Coleman | M | 80 | 13 years | |
| Seksan Kiatsupaibul | M | 51 |
University of Michigan
| 5 years |
| Jolynn Suko | F | - |
University of Michigan
| 2 years |
| Penna Andreas | M | - |
University of Michigan
| 4 years |
| Bethany Steinhaus | F | - |
University of Michigan
| 4 years |
| Jacob Cohen | M | - |
University of Michigan
| 4 years |
| Werlson Hwang | M | - |
University of Michigan
| 4 years |
| Selale Zaim Gorton | F | - |
University of Michigan
| 3 years |
| Andrew Bratt | M | - |
University of Michigan
| 9 years |
| Angela Prince | F | - |
University of Michigan
| 5 years |
| Jason Glasser | M | - |
University of Michigan
| 3 years |
| David Zolot | M | - |
University of Michigan
| 4 years |
| Ankit Patel | M | - |
University of Michigan
| 4 years |
| Ana Lucia Nadalin | F | - |
University of Michigan
| 2 years |
| Mike Vostrizansky | M | - |
University of Michigan
| 4 years |
| Elizabeth Laraki | F | - |
University of Michigan
| 5 years |
| Nadia Pazos | F | - |
University of Michigan
| 4 years |
| Katharine Melzer | F | - |
University of Michigan
| 4 years |
| Sejal Bell | M | - |
University of Michigan
| 4 years |
| Lake McGuire | M | - |
University of Michigan
| 3 years |
| David Rodrigues Pinto | M | - |
University of Michigan
| 4 years |
| Sailesh Ramakrishnan | M | - |
University of Michigan
| 4 years |
| David Moehring | M | - |
University of Michigan
| 6 years |
| Shelly Hundiwal | F | - |
University of Michigan
| 4 years |
| Leonard Post | M | 72 |
University of Michigan
| 7 years |
| Niraj Gupta | M | - |
University of Michigan
| 4 years |
| Rebecca L. Javid | F | - |
University of Michigan
| 4 years |
| John J. Guerra | M | - |
University of Michigan
| 2 years |
| Patti Glaza | F | - |
University of Michigan
| 2 years |
| Vadim Dulev | M | 52 |
University of Michigan
| 2 years |
| Scott Dvorkin | M | - |
University of Michigan
| 4 years |
| Thomas H. Crawford | M | - |
University of Michigan
| 2 years |
| Erin Springer | F | - |
University of Michigan
| 4 years |
| Sarah Yeung | F | - |
University of Michigan
| 4 years |
| Robert Kasdin | M | 66 |
University of Michigan
| 5 years |
| Susan Suh | F | - |
University of Michigan
| 4 years |
| Dave Hoffman | M | 55 |
University of Michigan
| 4 years |
| James H. Norman | M | - |
University of Michigan
| 5 years |
| David Quick | M | 44 |
University of Michigan
| 4 years |
| Ken Herbert | M | - |
University of Michigan
| 2 years |
| Adam Daniel Silver | M | - |
University of Michigan
| 4 years |
| Kelvin Pan | M | 44 |
University of Michigan
| 4 years |
| James Clarahan | M | - |
University of Michigan
| 4 years |
| Chuck Fortin | M | - |
University of Michigan
| 3 years |
| Jason Townsend | M | - |
University of Michigan
| 5 years |
| Alter Michelle Jessica | F | - |
University of Michigan
| 4 years |
| Nicholas Ranjan | M | - |
University of Michigan
| 3 years |
| Martin A. Downen | M | - |
University of Michigan
| 2 years |
| Matt Herman | M | - |
University of Michigan
| 4 years |
| Esteban Santos | M | 56 | 3 years | |
| Ehsan Sadri | M | - |
University of Michigan
| 4 years |
| Nicolas Regal | M | - |
University of Michigan
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| United Kingdom | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christophe Soulier
- Personal Network
